In previous work on the binding of pyridoxal 5-phosphate to the aspartate aminotransferase of pig heart it was shown that only the pyridoxamine form of this enzyme can be easily resolved, i.e. dissociated into apoenzyme and coenzyme, by means of phosphate anions, which probably compete with the phosphate ester group of pyridoxamine 5-phosphate for the cationic sites ofthe apoenzyme (Scardi, Scotto, laccarino & Scarano, 1963a,b) .
The conversion of the pyridoxal form of aspartate aminotransferase into the pyridoxamine form was obtained by interaction with L-aspartate or Lglutamate at room temperature for 15min. Other amino acids and dicarboxylic acids were ineffective under the same conditions, so that it seemed that only these amino acids, which are the major substrates, can effect this conversion (Scardi et al. 1963a, b) .
Owing to the importance of this conversion for the study of the coenzyme binding and the mode of action of the aspartate aminotransferase, further experiments were carried out with a series of amino acids and related compounds. In these experiments the extent of conversion ofthe pyridoxal form of the enzyme into the pyridoxamine form has been measured by means of the resolution procedure with phosphate anions, which permits one to distinguish between the two forms even if they are present in catalytic amounts (Scardi et al. 1963a, b; Bonavita, Guarneri & Scardi, 1964) .
The results of these experiments are reported in the present paper. A preliminary communication on this subject was made at the First Meeting of the Federation of European Biochemical Societies, held in London on 22-25 March 1964.
MATERIALS AND METHODS
Chemicals. Pyridoxal 5-phosphate and pyridoxamine 5-phosphate were obtained from the California Corp. for Biochemical Research, Los Angeles, Calif., U.S.A.; L-aspartic acid, L-glutamic acid, DL-oc-aminopimelic acid, DL-xaminoadipic acid, L-cz-aminobutyric acid, y-aminobutyric acid, L-histidine, L-proline, L-arginine, a-amino-n-valeric acid, isopropylamine, isopentylamine and ac-oxoglutaric acid were products from L. Light and Co. Ltd., Colnbrook, Bucks.; glycine, L-valine and L-lysmne were from the Nutritional Biochemicals Corp., Cleveland, Ohio, U.S.A.; Lphenylalanine, glutamic acid monomethyl ester (this product needed further purification before use), glutamic acid diethyl ester and aspartic acid diethyl ester were from the Mann Research Laboratories, New York, N.Y., U.S.A.; L-alanine and L-glutamine were from Hoffmann-La Roche, Basel, Switzerland; L-tyrosine and DL-oc-aminocaprylic acid were from the Distillation Products Industries, Rochester, N.Y., U.S.A.; DL-leucine was from Fluka A.G., Basel, Switzerland. Aspartic acid monoethyl ester was prepared in our Laboratory. All other chemicals were pure products obtained from various sources.
Preparation and assay of the enzyme. Aspartate aminotransferase was prepared from pig heart by the method of Jenkins, Yphantis & Sizer (1959) and further purified by column electrophoresis on Sephadex G-50. The electrolyte was 0-05M-sodium phosphate buffer, pH 7-5, and it was also used for eluting the enzyme (i.e. the faster-migrating zone) after 8 hr. run at 4°. The enzyme precipitated from the eluate with ammonium sulphate (70%, w/v) had a specific activity of 48-5, expressed as ,tmoles of oxaloacetic acid formed/mg. of protein/min. at 370 under the conditions described by Cammarata & Cohen (1951) . It was totally in the pyridoxal form and was proved to be homogeneous by analytical ultracentrifugation (Fig. 1) .
The enzyme activity was measured in a Beckman model DB spectrophotometer equipped with a Sargent model SRL recorder. The temperature of the cell compartment was kept constant within 0-10 by a constant circulating water bath.
Protein concentration was determined spectrophotometrically as described by Kalckar (1947) ; in this case a Unicam SP. 500 spectrophotometer was used.
Interaction ofthe enzyme with amino acids. A given amount of aspartate aminotransferase (about 200,ug.) was incubated at 370 for lOmin. in the presence of graded concentrations of the amino acid or related compound under examination, in a final volume of 1 ml. Each compound had been dissolved in water and the pH of the solution adjusted to 7 0 unless otherwise stated. The extent of interaction leading to the conversion of the pyridoxal form of the enzyme into the pyridoxamine form was calculated in terms of resolution; this was performed by adding lml. of M-KH2PO4 to the incubation mixture and reincubating for 15 min. more at the same temperature. Under these conditions only the pyridoxamine form of the enzyme is resolved. Then portions were taken and assayed for enzyme activity with and without the addition of an excess of pyridoxal 5-phosphate. The degree of resolution was calculated as reported by Scardi et al. (1963a,b) , i.e. percentage resolution= 100 (A -a)/A, where A and a are the enzyme activities measured in the presence and in the absence of pyridoxal 5-phosphate respectively. In general A was equal or almost equal to the activity of the enzyme before resolution, thus showing that no denaturation of the apoenzyme occurred.
RESULTS AND DISCUSSION
Interaction with amino acid8. The interaction between the pyridoxal form of aspartate amino-1965 transferase and certain amino acids causes a conversion into the pyridoxamine form, the extent of which can be measured in terms of percentage resolution after the action of the phosphate anions. Fig. 2 shows the percentage conversion of one form of the enzyme into the other as a finction of the logarithm of the reciprocal molar concentration of several amino acids. Where racemates are used, the concentration given in the Figure refers to the L-form only, since it was shown by Scardi et al. (1963a,b) that only L-amino acids interact with the enzyme. Glutamate has the highest affinity, followed by aspartate, as was to be expected on the basis of the data of Velick & Vavra (1962) . This accounts for our previous findings in which both glutamate and aspartate, being the major substrates of aspartate aminotransferase, seemed to be the only amino acids capable of converting the pyridoxal form of the enzyme into the pyridoxamine form. The sigmoid curves are almost parallel to each other.
To compare the affinities of different compounds for the pyridoxal form of the enzyme, the logarithm of the reciprocal concentration giving a 50% conversion was taken as a reference value and indicated as ' converting capacity' or PC50. In Table 1 several other amino acids of different type are compared in their capacity to convert the pyridoxal form of aspartate aminotransferase into the pyridoxamine form. The monoamino-dicarboxylic acids show the highest converting capacity, though they do not follow a well-defined rule, such as the distance between the two carboxyl groups. It seems, however, that the converting capacity alternates according to the number of carbon atoms: amino acids having an odd number of carbon atoms are more effective than their higher or lower homologues having an even number of carbon atoms. This alternation is Monoamino-monocarboxylic acids show a definite though smaller converting capacity, which seems to increase with the length of the carbon chain, reaching a maximum at a number of carbon atoms that we could not evaluate exactly, after which it decreases. Valine has no converting capacity, whereas leucine has a converting capacity as high as that of ao-aminobutyric acid; this can be explained by comparing the lengths of the non-polar portion of their molecules. As far as aromatic amino acids are concerned, phenylalanine has a converting capacity almost equal to that of the less effective monoamino-dicarboxylic acid. The converting capacity of tyrosine could not be measured because of its very low solubility at the pH values of our experiments. Histidine follows in order of decreasing capacity. Proline is ineffective, but two diamino-monocarboxylic acids, lysine and arginine, have PC5o values of 1-3 and 2-0 respectively.
The position of the amino group seems to be important, as shown by the results obtained with y-aminobutyric acid and 8-amino-n-valeric acid.
For some amino acids the pCso values were also measured at pH5 5 and 8 5 ( Conditions were the same as in Fig. 2 . o, Glutamate; 4o, glutamine; *, glutamate diethyl ester; A, glutamate monomethyl ester. a higher affinity than alanine, which was reported to interact with the pyridoxal form of aspartate aminotransferase to yield pyruvate with the concurrent conversion of the enzyme into its pyridoxamine form (Lis et al. 1960; Jenkins, 1961 pimelic acid seem to indicate that this is the case (Scardi & Marino, 1964) . Interaction with amino acid derivatiVe8. Fig. 3 shows the effect of esterification of carboxyl groups on the converting capacity of glutamic acid. Glutamate monomethyl ester is less than one-thousandth as active as glutamate, thus resembling oc-aminoadipate; this is very probably due to the decreased polarity of the portion of the molecule, which ends with the esterified carboxyl group. Glutamate diethyl ester and glutamine show sigmoid curves of different slope as compared with the curves exhibited by amino acids. This is probably due to the fact that glutamate diethyl ester and glutamine resemble amines. Some simple amines were tested and only some isomeric amines proved effective: isopropylamine and isopentylamine showed sigmoid curves parallel to those exhibited by glutamate diethyl ester and glutamine and PC5o values of the same order of magnitude, i.e. 3-95 and 3-30 respectively. Aspartate monoethyl and diethyl esters have no effect at all on the pyridoxal form of aspartate aminotransferase.
Our experimental results, indicating that conversion of the pyridoxal form of aspartate aminotransferase into the pyridoxamine form can be performed by any amino acid having certain structural features, should contribute to the understanding of the mechanism of action of this enzyme. Further, the results contribute towards the present knowledge of the number of possible substrates of aspartate aminotransferase. The present research was made possible through the support and the sponsorship of the U.S. Army Department, through its European Research Office.
